Newland Pharmaceutical Co., Ltd. (SHE:301277)
14.03
-0.19 (-1.34%)
Last updated: Jun 26, 2025
Newland Pharmaceutical Market Cap
Newland Pharmaceutical has a market cap or net worth of 5.49 billion as of June 27, 2025. Its market cap has increased by 33.61% in one year.
Market Cap
5.49B
Enterprise Value
4.71B
Revenue
761.64M
Ranking
n/a
PE Ratio
31.61
Stock Price
14.03
Market Cap Chart
Since November 16, 2022, Newland Pharmaceutical's market cap has increased from 5.31B to 5.49B, an increase of 3.49%. That is a compound annual growth rate of 1.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 26, 2025 | 5.49B | 41.82% |
Dec 31, 2024 | 3.87B | -6.96% |
Dec 29, 2023 | 4.16B | 8.12% |
Dec 30, 2022 | 3.85B | -27.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jiangsu Hengrui Medicine | 345.12B |
Shenzhen Mindray Bio-Medical Electronics | 275.14B |
WuXi AppTec | 189.25B |
Zhangzhou Pientzehuang Pharmaceutical., | 121.15B |
Sichuan Biokin Pharmaceutical | 119.30B |
Aier Eye Hospital Group | 115.08B |
Shanghai United Imaging Healthcare | 105.85B |
Yunnan Baiyao Group Co.,Ltd | 100.51B |